BIBCL - DAY CHART - 24.12.2022 - BAHAVAN CAPITALBHARAT BIOLOGICAL & IMMUNOLOGICAL CORPORATION As Per Day Chart Analysis ABOVE 46 TARGET 50
Though DII been in selling spree but DII Buying had been highly to be noted
DATE FII DII
21.12.2022 1119.11 cr (Net Selling) 1757.37 cr (Net Buying)
22.12.2022 928.63 cr (Net Buying) 2206.59 cr (Net Buying)
Key stats
Market capitalization
1.003BINR
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.19INR
About BHARAT IMMUNOLOGICALS & BIOLOG
ISIN
INE994B01014
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
bibcol.com
CEO
Chaitanya Murti
Headquarters
Bulandshahr
Founded
1989
Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacturing and producing pharmaceutical products such as oral polio vaccines; zinc tablet and diarrhea management kit; and ready to use therapeutic food. It operates through the following business segments: Oral Polio Vaccine (OPV), Zinc Tablets, BIB VIT, and BIBSANIT. The company was founded on March 10, 1989 and is headquartered in Bulandshahr, India.
Bharat Biotech - Super Strong Close
Price moving further up to reach the previous ATH and closed strong and no doubt it will move up considerably . . .
I tried to buy this @ 14 -18 rupees and never get a chance, so its only a watch game for me.
Anyone holding this from lower levels can leave a message . . .
Bharat Biotech - Talk of the town - 6 was the best entry.As these guys are getting there vaccines for this pandemic the stocks moves high on every day and there is no chance for the retail traders to get in to the trade.
As you see from the beginning of this stock behavior when these stock reaches 6 levels it bounces back to 50+ levels and then fall back
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0